---
title: "What is tirzepatide (GIP/GLP-1) and how is it different from semaglutide?"
canonical_url: https://peptidelibrary.app/faq/what-is-tirzepatide-gipglp-1-and-how-is-it-different-from-semaglutide
updated: 2026-02-16
publisher: Peptide Library
notice: "Research and educational use only. Not medical advice."
---

# What is tirzepatide (GIP/GLP-1) and how is it different from semaglutide?

Tirzepatide is studied as a **dual incretin agonist**, targeting:
- **GIP (glucose-dependent insulinotropic polypeptide) receptor**
- **GLP-1 receptor**

Semaglutide primarily targets the **GLP-1 receptor**.

In research discussions, the key difference is **single-pathway (GLP-1)** vs **dual-pathway (GIP + GLP-1)** signaling.
